🇺🇸 FDA
Patent

US 12343448

Use of stem cells produced by stem cell generator in treatment of hematopoietic damage

granted A61KA61K35/28A61K38/16

Quick answer

US patent 12343448 (Use of stem cells produced by stem cell generator in treatment of hematopoietic damage) held by East China University of Science and Technology expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
East China University of Science and Technology
Grant date
Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K35/28, A61K38/16, A61K38/18, A61P